Answers are grounded in this paper and cite their sources.
With aging, the accumulation of oxidative stress and cellular senescence drives the progression of osteoporosis. As a conserved cellular stress response, ribonucleases cleave cytoplasmic transfer RNAs (tRNAs) to generate tRNA-derived stress-induced RNAs (tiRNAs) with versatile functions. However, their biological functions in regulating osteoporosis remain poorly understood. In our study, we observed increased angiogenin (ANG) levels in aged Bone Marrow Stromal Cells (BMSCs) and found that ANG promotes age-dependent accumulation of 5’-tiRNA-Glu − CTC by cleaving tRNA-Glu under oxidative stress. The 5’-tiRNA-Glu − CTC disrupts the stability of anti-senescence and pro-osteogenic mRNAs, leading to bone-fat imbalance and thereby accelerating bone loss. Therapeutically, targeted suppression of 5′-tiRNA-Glu − CTC via an Antisense Oligonucleotide (ASO)-based strategy effectively rescued ANG(S28N)-induced and age-associated bone loss. Consistently, pharmacological inhibition of ANG with NCI-65,828 mitigated BMSC senescence and bone loss. Clinically, elevated serum levels of 5’-tiRNA-Glu − CTC negatively correlated with bone formation markers in osteoporosis patients, suggesting its potential as an associated biomarker for diagnosing age-related osteoporosis. Collectively, our findings establish the “oxidative stress-ANG-tiRNA” axis as a critical driver of age-related bone loss, unveiling a novel pathogenic mechanism and positioning ANG and 5’-tiRNA-Glu − CTC as promising therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Kuang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: